Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xeris Biopharma Holdings (XERS) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Xeris Biopharma Holdings (XERS) over the last 6 years, with Q3 2025 value amounting to $1.2 million.

  • Xeris Biopharma Holdings' Interest & Investment Income fell 325.81% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 million, marking a year-over-year decrease of 2404.86%. This contributed to the annual value of $5.3 million for FY2024, which is 1199.75% up from last year.
  • Per Xeris Biopharma Holdings' latest filing, its Interest & Investment Income stood at $1.2 million for Q3 2025, which was down 325.81% from $948000.0 recorded in Q2 2025.
  • Xeris Biopharma Holdings' 5-year Interest & Investment Income high stood at $1.9 million for Q1 2024, and its period low was $66000.0 during Q3 2021.
  • In the last 5 years, Xeris Biopharma Holdings' Interest & Investment Income had a median value of $1.1 million in 2023 and averaged $854947.4.
  • Per our database at Business Quant, Xeris Biopharma Holdings' Interest & Investment Income plummeted by 9653.81% in 2021 and then skyrocketed by 253285.71% in 2022.
  • Over the past 5 years, Xeris Biopharma Holdings' Interest & Investment Income (Quarter) stood at $70000.0 in 2021, then skyrocketed by 2532.86% to $1.8 million in 2022, then crashed by 39.93% to $1.1 million in 2023, then dropped by 17.8% to $910000.0 in 2024, then increased by 27.25% to $1.2 million in 2025.
  • Its Interest & Investment Income was $1.2 million in Q3 2025, compared to $948000.0 in Q2 2025 and $1.2 million in Q1 2025.